Possible correlation between Triglyceride/HDL ratio and subclinical myocardial damage in patients with cardiovascular risk factors
Year: 2025
Type: article
Study design: Observational Study
Abstract: AIMS: The triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio is considered a predictor of cardiovascular (CV) disease. The aim of the study was to evaluate the TG/HDL-C ratio as CV risk factor and its possible correlation with subclinical myocardial damage. METHODS: We enrolled 545 patients, all of whom underwent oral glucose tolerance test (OGTT). The TG/HDL-C ratio was calculated as the arithmetic ratio between triglyceride and HDL cholesterol concentrations. RESULTS: Patients were stratified into four quartiles based on TG/HDL-C values. From the first to the fourth quartile, there was a progressive deterioration in glucose metabolism, as evidenced by significant increases in fasting plasma glucose (FPG), 2-hour glucose, fasting plasma insulin (FPI), 2-hour insulin (all p < 0.001), along with a reduction in insulin sensitivity. Left ventricular global systolic function, assessed via global longitudinal strain (GLS), showed progressive deterioration across quartiles (p < 0.001). Logistic regression analysis revealed that each one-unit increase in the TG/HDL-C ratio was associated with a 61 % higher likelihood of having a pathological GLS (crude odds ratio: 1.61). CONCLUSION: In conclusion, patients with elevated TG/HDL-C ratios exhibit subclinical myocardial dysfunction even in the absence of clinical symptoms. The TG/HDL-C ratio may represent a simple marker for early identification of CV risk.
Authors: Velia Cassano, Graziella D’Arrigo, Mercedes Gori, Giovanni Tripepi, Giuseppe Armentaro, Carlo A. Pastura, Giandomenico Severini, Mariarosangela Scarcelli, Daniele Dallimonti Perini, Sofia Miceli, Raffaele Maio, Vanessa T. Fiorentino, Elena Succurro, Marta L. Hribal, Giorgio Sesti, Francesco Andreozzi, Angela Sciacqua
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,410
OpenAlex ID: W4413834966
